Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Global First Engineered Exosome with INCI Name — ImmVira Leads a New Era in International Cosmetic Ingredients
      Biotech

      Global First Engineered Exosome with INCI Name — ImmVira Leads a New Era in International Cosmetic Ingredients

      April 11, 2025
      2025 CANADA GAIRDNER AWARDS RECOGNIZE WORLD-RENOWNED SCIENTISTS FOR  TRANSFORMATIVE CONTRIBUTIONS TO RESEARCH IMPACTING HUMAN HEALTH
      Biotech

      2025 CANADA GAIRDNER AWARDS RECOGNIZE WORLD-RENOWNED SCIENTISTS FOR TRANSFORMATIVE CONTRIBUTIONS TO RESEARCH IMPACTING HUMAN HEALTH

      April 11, 2025
      VCI BIOFUELS GROUP SIGNS DEFINITIVE MERGER AGREEMENT WITH INTERNATIONAL MEDIA ACQUISITION CORP. TO PUBLICLY LIST ON THE NASDAQ
      Biotech

      VCI BIOFUELS GROUP SIGNS DEFINITIVE MERGER AGREEMENT WITH INTERNATIONAL MEDIA ACQUISITION CORP. TO PUBLICLY LIST ON THE NASDAQ

      April 10, 2025
      Lucid Diagnostics Announces Pricing of Public Offering of Common Stock
      Biotech

      Lucid Diagnostics Announces Pricing of Public Offering of Common Stock

      April 10, 2025
      Infinitopes Granted Phase I/IIa Clinical Trial Application Approval to Evaluate Precision Vaccine Targeting Early-Stage Oesophageal Cancer
      Biotech

      Infinitopes Granted Phase I/IIa Clinical Trial Application Approval to Evaluate Precision Vaccine Targeting Early-Stage Oesophageal Cancer

      April 9, 2025
      Cytora Reports Successful Results of Phase 1/2a Trial of Stem Cell Treatment for Diabetic Foot Ulcers
      Biotech

      Cytora Reports Successful Results of Phase 1/2a Trial of Stem Cell Treatment for Diabetic Foot Ulcers

      April 9, 2025
      Precision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma Services with the SOPHiA DDM™ Platform and its Liquid Biopsy Capabilities
      Biotech

      Precision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma Services with the SOPHiA DDM™ Platform and its Liquid Biopsy Capabilities

      April 8, 2025
      Xeltis successfully passes evaluation phase for €10million investment from European Innovation Council
      Biotech

      Xeltis successfully passes evaluation phase for €10million investment from European Innovation Council

      April 8, 2025
      MicuRx: 15 Clinical and Preclinical Research Studies to be Presented at ESCMID Global 2025
      Biotech

      MicuRx: 15 Clinical and Preclinical Research Studies to be Presented at ESCMID Global 2025

      April 8, 2025
      FIECON Joins Herspiegel to Expand Global Life Science Commercialization Services
      Biotech

      FIECON Joins Herspiegel to Expand Global Life Science Commercialization Services

      April 7, 2025
      « 1 … 37 38 39 40 41 … 140 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026